^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    RCSD1-ABL2 fusion

    i
    Other names: RCSD1, RCSD Domain Containing 1, RCSD Domain-Containing Protein 1, Protein Kinase Substrate CapZIP, CapZ-Interacting Protein, CAPZIP, Protein Kinase Substrate MK2S4, CapZ Interacting Protein, MK2S4, ABL2, ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase, V-Abl Abelson Murine Leukemia Viral Oncogene Homolog 2, C-Abl Oncogene 2, Non-Receptor Tyrosine Kinase, Abelson Tyrosine-Protein Kinase 2, Abelson-Related Gene Protein, Tyrosine-Protein Kinase ABL2, Tyrosine-Protein Kinase ARG, ABLL, ARG, V-Ab
    Entrez ID:
    27; 92241
    Related biomarkers:
    Fusion
    1year
    Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene. (PubMed, Leuk Lymphoma)
    No abstract available
    Journal
    |
    ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase) • RCSD1 (RCSD Domain Containing 1)
    |
    ABL2 fusion • RCSD1-ABL2 fusion